MediSapiens, world’s first software company for personalized cancer medicine in oncology clinics and drug development, completed $ 1 million (EUR 0.8 million) seed round investment from Veraventure, ETFIII advised by Eqvitec Partners, VTT Ventures and Lifeline Ventures. MediSapiens is based on scientific research at the VTT Technical Research Centre of Finland and its collaborators. MediSapiens [...]
Posts tagged as:
